Drug-Free Pain Relief Prescription Digital Therapeutics for Pain Management Theranica Bio-Electronics Theranica develops advanced, clinically proven, safe and affordable digital therapeutics, addressing some of the world’s most prevalent neurological pain diseases. We harness a pain inhibition mechanism known as Conditioned Pain Modulation (CPM). This is the notion that in certain diseases, including migraine, patients have dysfunctional pain processing; a harmless stimulus is […]
Location: United States, New Jersey, Montclair
Employees: 11-50
Total raised: $86M
Founded date: 2016
Investors 4
| Date | Name | Website |
| - | Lightspeed... | lsvp.com |
| - | LionBird | lionbird.c... |
| - | Startup Cr... | startupcre... |
| - | aMoon Fund | amoon.fund... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 30.08.2022 | Series C | $45M | - |
| 18.03.2019 | Series B | $35M | - |
| 03.07.2017 | Series A | $6M | Lightspeed... |
Mentions in press and media 18
| Date | Title | Description |
| 25.07.2024 | New Study Evaluates Use of the Nerivio® REN Wearable for Treatment of Migraine in Children Under the Age of 12 | Nerivio, currently indicated for use in ages 12 and older, demonstrates study results in younger children with migraine. BRIDGEWATER, N.J. and NETANYA, Israel, July 25, 2024 /PRNewswire/ -- Theranica, a neuromodulation therapeutics company,... |
| 10.07.2024 | Colorado Medicaid's Decision to Cover the Nerivio® REN Wearable Expands Access for Nearly Two Million Americans to Drug-Free, Dual Use Migraine Treatment | Colorado Medicaid is the third federally-funded insurance plan to recognize the REN wearable as safe, effective migraine relief for adolescents and adults ages 12 years and older BRIDGEWATER, N.J. and NETANYA, Israel, July 10, 2024 /PRNewsw... |
| 21.05.2024 | DC Medicaid Becomes the First Medicaid Plan to Cover the Nerivio® REN Wearable, a Non-Drug Treatment for Migraine | This represents the second federally funded insurance plan, after the Veteran Administration (VA), to cover the innovative therapy BRIDGEWATER, N.J. and NETANYA, Israel, May 21, 2024 /PRNewswire/ -- Theranica, a neuromodulation therapeutics... |
| 10.04.2024 | Dr. Reddy’s launches migraine management wearable device, Nerivio, in Germany | Dr. Reddy’s Laboratories launched the drug-free, non-invasive migraine management wearable device Nerivio in Germany through its step-down subsidiary, betapharm. The launch marks the company’s entry into digital therapeutics in Europe. Neri... |
| 20.02.2024 | Highmark Grants Commercial Coverage to Theranica’s Wearable for Migraine Treatment | Nerivio is indicated for dual-use in people 12 years and older What You Should Know: – Theranica, a leader in neuromodulation devices for migraine and other chronic pain conditions, announced today that Highmark Inc. has included its Nerivi... |
| 30.08.2022 | Theranica ropes in $45M for smartphone-connected migraine modulation armband | Fundraising can be a constant headache for many health tech startups—but not for Theranica. The company has managed to keep a steady stream of financing coming in and investors interested in its technology since its 2016 founding. The most ... |
| 29.08.2022 | Theranica Raises $45M in Series C Funding | Theranica, a Netanya, Israel- and Montclair, NJ-based prescribed digital therapeutics company developing advanced neuromodulation devices for migraine and other idiopathic pain conditions, closed its Series C funding round, with a first clo... |
| 29.08.2022 | Israeli startup Theranica, maker of migraine-zapping device, nabs $45m investment Into the Land: The Forgery Scandal | Israeli startup Theranica, the developer of a medical device to treat acute migraines, has pulled in a new investment of $45 million for an ongoing Series C round the company plans to finalize in the fall. The investment was led by Philadel... |
| 29.08.2022 | Theranica raises $45M for migraine digital therapeutic | Photo: Theranica |
| 29.08.2022 | Theranica Secures $45M Series C Funding | MONTCLAIR, NJ, Theranica, a prescribed digital therapeutics company, announced the closing of a $45M Series C funding round. >> Click here for more funding data on Theranica >> To export Theranica funding data to PDF and Exc... |
Show more